Monday, December 13, 2004

From Health Canada:
Bextra (valdecoxib) - Cardiovascular Risks and Serious Skin Reactions
Dear Health Care Professional,

Pfizer Canada Inc., following discussions with Health Canada, would like to inform you of new safety information for BEXTRA* (valdecoxib) tablets. The Product Monograph for BEXTRA is being revised to reflect the following...more.

No comments: